Position in GOSS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$14,618
-$56,576 QoQ
Shares Held
88,599
-59.1% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 168 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GOSS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. GOSS ranks #306 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in GOSS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,618 | 88,599 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $71,194 | 216,396 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $666,093 | 214,869 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $591,907 | 225,060 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $284,190 | 231,049 | Shares | Sole | 2025-08-12 | |
| 2024-06-30 | $2,553 | 2,834 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $4,016 | 3,404 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,107 | 3,404 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,835 | 3,404 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $9,370 | 7,809 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $107,554 | 85,361 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $182,316 | 84,017 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $981,557 | 81,933 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $616,450 | 73,650 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $737,452 | 84,960 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,032,195 | 91,264 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,138,175 | 90,547 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $709,070 | 87,324 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $723,979 | 78,268 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $795,918 | 82,308 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $897,243 | 72,300 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,015,235 | 78,095 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $612,136 | 60,309 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||